Last reviewed · How we verify

NCT07519746: PROINGA

Satisfaction and Quality of Life Among Prosthetic Users in Gaza Governorate ,

Completed Last updated 9 April 2026
What this trial tests

trial testing Observational Study - No Intervention in Amputation in 128 participants. Completed in 25 March 2026.

Timeline
1 September 2025
Primary endpoint
15 March 2026
25 March 2026

Quick facts

Lead sponsorYeditepe University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment128
Start date1 September 2025
Primary completion15 March 2026
Estimated completion25 March 2026
Sites1 location across Palestinian Territories

Drugs / interventions tested

Conditions studied

Sponsor

Yeditepe University

Who can join

18 and older, any sex, with Amputation or Prosthesis User. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prosthetic devices help amputees regain mobility and improve appearance. When patients are satisfied with their prosthesis, they are more likely to use it consistently, leading to better rehabilitation outcomes. In Gaza, the 2023 Gaza War caused a rise in traumatic amputations and limited access to healthcare and prosthetic services. This makes rehabilitation more difficult, affecting both physical and mental health. Research on patient satisfaction and quality of life (QoL) among lower limb prosthetic users in Gaza is limited. This study evaluates satisfaction and QoL in this population, aiming to provide information to improve prosthetic care and guide interventions tailored to local needs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Amputation

Currently open trials in the same condition.

Other Yeditepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07519746.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing